Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Omaha, NE
NPI
1659425288
Since 2007
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
11930 Arbor St, Suite 200
Omaha, NE, 68144
Phone (402) 697-1601
Medicare paid, 2024
$26K
308 services
Medicare patients, 2024
123
Average age 63
Drug cost, 2024
$2.0M
3,527 prescriptions
Company payments, 2025
$1,812
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard V Andrews was code 99214 (office e&m - established), 260 times for 102 patients. In total Richard V Andrews billed 308 services in 6 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 260 | 102 | $82.16 | $21K |
| 99205 Office E&M - New | Office | 17 | 17 | $154.27 | $2,623 |
| 99215 Office E&M - Established | Office | 16 | 15 | $89.79 | $1,437 |
By year: 2022 $38K for 541 services; 2023 $34K for 452 services; 2024 $26K for 308 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard V Andrews prescribed most often to Medicare patients was Rufinamide, with 144 prescriptions and refills. In total Richard V Andrews wrote 3,527 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rufinamide Generic | 144 | 150 | 11 | $162K |
| Lacosamide Generic | 138 | 166 | 16 | $27K |
| Felbamate Generic | 132 | 163 | 15 | $33K |
| Quetiapine Fumarate Generic | 122 | 159 | 14 | $1,567 |
| Topiramate Generic | 106 | 159 | 16 | $1,355 |
| Memantine Hcl Er Memantine Hcl | 106 | 129 | 12 | $8,730 |
| Clobazam Generic | 93 | 101 | Under 11 | $10K |
| Levetiracetam Generic | 92 | 165 | 17 | $4,089 |
| Xcopri Cenobamate | 82 | 83 | Under 11 | $143K |
| Aripiprazole Generic | 73 | 99 | Under 11 | $2,310 |
| Trazodone Hcl Generic | 68 | 93 | 12 | $630 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 65 | 107 | 13 | $605 |
| Zonisamide Generic | 64 | 89 | Under 11 | $2,283 |
| Tiagabine Hcl Generic | 63 | 73 | Under 11 | $29K |
| Carbamazepine Er Carbamazepine | 59 | 89 | Under 11 | $10K |
Brand drugs: - claims; generic drugs: 2,913 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard V Andrews $1,812 ($1,812 in general payments such as food, travel and fees) from 14 companies. The largest payer was Harmony Biosciences LLC with $460.
| Company | Payments | Amount |
|---|---|---|
| Harmony Biosciences LLC HRMY | 26 | $460 |
| Axsome Therapeutics, Inc. AXSM | 5 | $388 |
| UCB, Inc. UCB.BR | 18 | $301 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $145 |
| SK Life Science, Inc. | 3 | $124 |
| Catalyst Pharmaceuticals, Inc. CPRX | 4 | $115 |
| Neurelis, Inc. | 2 | $82.59 |
| Eisai Inc. 4523.T | 3 | $58.55 |
| Pfizer Inc. PFE | 2 | $37.12 |
| Impel Pharmaceuticals LLC | 1 | $21.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.